Financing, Equity Capital Markets

Rocket Pharmaceuticals, Inc.

12/20
|
$299.0 Million
Piper Sandler served as bookrunner for Rocket Pharmaceuticals, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma